347
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Mesogenic properties of two 1,3,4-oxadiazole-based bent-core geometrical isomers

, &
Pages 421-427 | Received 30 Oct 2012, Accepted 29 Nov 2012, Published online: 04 Jan 2013
 

Abstract

Two new symmetrical oxadiazole-based bent-core mesogens bearing cis and trans geometrical stereoisomer tails, geranyloxy and neryloxy, have been synthesised and the effect of the cistrans geometric configuration of the terminal chains on the thermal profile and mesomorphic behaviour were investigated using differential scanning calorimetry and polarised optical microscopy. The transtrans stereoisomer compound 4g with terminal geranyloxy chains exhibited a nematic phase characterised by the schlieren texture, which contained both 2- and 4-brush defects and remarkably no smectic mesophases. The ciscis stereoisomer neryloxy derivative 4n has a much lower melting temperature but did not exhibit mesomorphism. In an attempt to further lower the melting point of the nematic mesophase, a binary mixture study was carried out between the geranyloxy and neryloxy 2,5-bis(4-hydroxyphenyl)-1,3,4-oxadiazole derivatives. The mesomorphism is retained up to 50% ratio, with a cross-over reached at 70% of the geranyloxy transtrans stereoisomer 4g, resulting in monotropic behaviour of the mixture. Once neryloxy ciscis stereoisomer homologue 4n is in excess, the mesophase is completely suppressed.

Acknowledgement

This work was supported by the Engineering and Physical Sciences Research Council under Project No. EP/G023093/1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.